Alfonso G Zulueta's Net Worth

$63.1 Million

Estimate Recalculated Nov 11, 2024 07:36AM EST

Who is Alfonso G Zulueta

Alfonso G Zulueta has an estimated net worth of $63.1 Million. This is based on reported shares across multiple companies, which include Syneos Health, Inc., LILLY ELI & CO, CTS CORP, AMARIN CORP PLC\UK, and Calidi Biotherapeutics, Inc..

SEC CIK

Alfonso G Zulueta's CIK is 0001596336

Past Insider Trading and Trends

2020 was Alfonso G Zulueta's most active year for acquiring shares with 9 total transactions. Alfonso G Zulueta's most active month to acquire stocks was the month of January. 2019 was Alfonso G Zulueta's most active year for disposing of shares, totalling 10 transactions. Alfonso G Zulueta's most active month to dispose stocks was the month of January. 2021 saw Alfonso G Zulueta paying a total of $6,107,027.49 for 60,097 shares, this is the most they've acquired in one year. In 2019 Alfonso G Zulueta cashed out on 76,086 shares for a total of $7,720,528.52, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Syneos Health, Inc.

Investor
Updated Sep 28, 2023
Form 4
-100.00%
-8.36K
$43.00
-$150.20K
Sep 28, 2023
Disposition
Sep 28
Form 4
139.22%
4.86K
May 30, 2023
8.36K
Grant
May 25
Form 4
434.10%
2.84K
May 27, 2022
3.49K
Grant
May 25
Form 4
654.00
Jan 20, 2022
654.00
Grant
Jan 18
Form 3
Jan 20, 2022
Showing 5 results

LILLY ELI & CO

SVP & President, Lilly Int'l
Updated Feb 10, 2021
Form 4
142.40%
39.74K
$205.77
$5.97M
Feb 10, 2021
72.32K
Grant
Feb 08
Form 4
-21.16%
-7.49K
$207.97
-$1.56M
Feb 03, 2021
32.58K
Options
Feb 01
Form 4
-37.10%
-11.00K
$170.00
-$1.87M
Jul 13, 2020
23.27K
Sale
ScheduledJul 09
Form 4
-36.44%
-17.00K
$162.94
-$2.77M
Jun 18, 2020
34.28K
Sale
ScheduledJun 16
Form 4
-17.65%
-10.00K
$150.00
-$1.50M
Jun 09, 2020
51.28K
Sale
ScheduledJun 05
Form 4
91.52%
35.08K
Feb 13, 2020
77.99K
Grant
Feb 11
Form 4
-16.00%
-7.30K
$139.64
-$1.02M
Feb 04, 2020
42.91K
Options
Feb 01
Form 4
-13.31%
-4.50K
$120.00
-$540.00K
Dec 09, 2019
33.90K
Sale
ScheduledDec 06
Form 4
-11.75%
-4.50K
$117.00
-$526.50K
Sep 23, 2019
38.37K
Sale
ScheduledSep 20
Form 4/A
-33.73%
-19.50K
$112.96
-$2.20M
Sep 09, 2019
38.31K
Sale
ScheduledSep 03
Form 4
-33.73%
-19.50K
$112.91
-$2.20M
Sep 04, 2019
42.87K
Sale
ScheduledSep 03
Form 4
-14.75%
-10.00K
$124.65
-$1.25M
Apr 16, 2019
62.32K
Sale
ScheduledApr 12
Form 4
80.59%
37.54K
$120.17
$2.55M
Feb 06, 2019
88.61K
Grant
Feb 04
Form 4
-8.57%
-4.36K
$119.86
-$523.07K
Feb 05, 2019
51.07K
Options
Feb 01
Form 4
-8.84%
-4.00K
$120.00
-$480.00K
Feb 04, 2019
45.72K
Sale
ScheduledJan 31
Form 4
-13.40%
-7.00K
$114.64
-$802.48K
Oct 05, 2018
49.70K
Sale
ScheduledOct 04
Form 4
-10.31%
-6.00K
$106.31
-$637.83K
Sep 19, 2018
56.70K
Sale
ScheduledSep 17 - Sep 18
Form 4
-10.91%
-7.13K
$81.45
-$580.98K
Feb 05, 2018
62.62K
Options
Feb 01
Form 4
47.54%
19.04K
$87.60
$816.08K
Jan 31, 2018
63.48K
Grant
Jan 29
Form 4
-8.10%
-3.53K
$86.00
-$303.75K
Dec 05, 2017
44.44K
Sale
ScheduledDec 04
Form 4
-4.39%
-2.00K
$83.67
-$167.59K
Nov 13, 2017
47.95K
Sale
ScheduledNov 10
Form 4
-24.76%
-15.00K
$77.66
-$1.16M
Feb 08, 2017
49.87K
Sale
Feb 06
Form 4
-4.91%
-3.13K
$77.03
-$240.87K
Feb 03, 2017
64.87K
Options
Feb 01
Form 4
66.38%
29.14K
$75.38
$991.25K
Jan 31, 2017
77.33K
Grant
Jan 27
Form 4
-21.02%
-12.00K
$76.27
-$915.24K
Apr 28, 2016
49.30K
Sale
Apr 27
Form 4
-8.05%
-5.00K
$78.75
-$393.75K
Feb 02, 2016
61.27K
Sale
Jan 29
Form 4
24.87%
13.69K
$81.96
$576.59K
Jan 28, 2016
72.93K
Grant
Jan 26
Form 4
-14.94%
-9.67K
$69.95
-$133.05K
Nov 23, 2015
59.21K
Options
Nov 20
Form 4
28.02%
11.53K
$70.97
$818.43K
Jan 30, 2015
56.76K
Grant
Jan 28
Form 4
-31.87%
-19.25K
$61.30
-$103.79K
Nov 12, 2014
45.21K
Options
Nov 07
Form 4
-10.08%
-4.38K
$64.85
-$284.30K
Oct 03, 2014
43.16K
Options
Oct 01
Form 4
49.64%
11.33K
$54.23
$614.59K
Jan 30, 2014
38.12K
Grant
Jan 28
Form 3
Jan 10, 2014
26.79K
Showing 33 results

CTS CORP

Investor
Updated Nov 08, 2024
Form 4
8.00%
2.40K
Nov 08, 2024
32.41K
Grant
Nov 07
Form 4
13.63%
3.60K
Nov 06, 2023
30.01K
Grant
Nov 02
Form 4
13.30%
3.10K
Nov 14, 2022
26.41K
Grant
Nov 10
Form 4
18.26%
3.60K
$36.69
$132.08K
Nov 05, 2021
23.31K
Grant
Nov 04
Form 4
27.07%
4.20K
$29.23
$122.77K
Nov 06, 2020
19.71K
Grant
Nov 05
Form 4
25.73%
2.66K
$22.40
$59.64K
Mar 13, 2020
13.01K
Purchase
Mar 11 - Mar 13
Form 4
20.35%
1.75K
$22.83
$39.95K
Mar 10, 2020
10.35K
Purchase
Mar 09 - Mar 10
Form 4
104.76%
4.40K
$27.81
$122.36K
Nov 08, 2019
8.60K
Grant
Nov 07
Form 4
4.20K
$28.85
$121.17K
Nov 09, 2018
4.20K
Grant
Nov 08
Form 3
Apr 18, 2018
2.50K
Showing 10 results

AMARIN CORP PLC\UK

Investor
Updated Jun 29, 2022
Form 4
209.67K
Jun 29, 2022
209.67K
Grant
Jun 27
Form 4
403.72K
May 20, 2022
403.72K
Grant
May 16
Form 3
May 20, 2022
Showing 3 results

Calidi Biotherapeutics, Inc.

Investor
Updated Jan 04, 2024
Form 4
4.42%
5.64K
$1.80
$10.16K
Jan 04, 2024
133.30K
Grant
Dec 21
Showing 1 results